129 related articles for article (PubMed ID: 1664696)
1. Basic FGF-SAP mitotoxin in the hippocampus. Specific lethal effect on cells expressing the basic FGF receptor.
Gonzalez AM; Lappi DA; Buscaglia ML; Carman LS; Gage FH; Baird A
Ann N Y Acad Sci; 1991; 638():442-4. PubMed ID: 1664696
[No Abstract] [Full Text] [Related]
2. The basic fibroblast growth factor-saporin mitotoxin acts through the basic fibroblast growth factor receptor.
Lappi DA; Maher PA; Martineau D; Baird A
J Cell Physiol; 1991 Apr; 147(1):17-26. PubMed ID: 1645359
[TBL] [Abstract][Full Text] [Related]
3. Basic fibroblast growth factor-saporin mitotoxin. In vitro studies of its cell-killing activity and of substances that alter that activity.
Martineau D; Lappi DA; Amburn E; Baird A
Ann N Y Acad Sci; 1991; 638():438-41. PubMed ID: 1785818
[No Abstract] [Full Text] [Related]
4. Biological and chemical characterization of basic FGF-saporin mitotoxin.
Lappi DA; Martineau D; Baird A
Biochem Biophys Res Commun; 1989 Apr; 160(2):917-23. PubMed ID: 2541718
[TBL] [Abstract][Full Text] [Related]
5. Anti-B16-F10 melanoma activity of a basic fibroblast growth factor-saporin mitotoxin.
Ying W; Martineau D; Beitz J; Lappi DA; Baird A
Cancer; 1994 Aug; 74(3):848-53. PubMed ID: 8039113
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor-2-toxin induced cytotoxicity: differential sensitivity of co-cultured vascular smooth muscle cells and endothelial cells.
Lin PH; Ren D; Hirko MK; Kang SS; Pierce GF; Greisler HP
Atherosclerosis; 1998 Apr; 137(2):277-89. PubMed ID: 9622271
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo.
Beitz JG; Davol P; Clark JW; Kato J; Medina M; Frackelton AR; Lappi DA; Baird A; Calabresi P
Cancer Res; 1992 Jan; 52(1):227-30. PubMed ID: 1309225
[TBL] [Abstract][Full Text] [Related]
8. Receptor-targeted delivery of an intracellular toxin to outer hair cells by fibroblast growth factor.
Dazert S; Baird A; Ryan AF
Hear Res; 1998 Jan; 115(1-2):143-8. PubMed ID: 9472743
[TBL] [Abstract][Full Text] [Related]
9. Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines.
Tetzke TA; Caton MC; Maher PA; Parandoosh Z
Clin Exp Metastasis; 1997 Nov; 15(6):620-9. PubMed ID: 9344046
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of a homogeneous chemical conjugate between basic fibroblast growth factor and saporin.
Buechler YJ; Sosnowski BA; Victor KD; Parandoosh Z; Bussell SJ; Shen C; Ryder M; Houston LL
Eur J Biochem; 1995 Dec; 234(3):706-13. PubMed ID: 8575426
[TBL] [Abstract][Full Text] [Related]
11. Selective elimination of fibroblasts from pancreatic islet monolayers by basic fibroblast growth factor-saporin mitotoxin.
Beattie GM; Lappi DA; Baird A; Hayek A
Diabetes; 1990 Aug; 39(8):1002-5. PubMed ID: 2165003
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor complexed to the cytotoxin saporin is growth inhibitory but not cytotoxic for embryonal carcinoma cells.
Miller K; Wilder PJ; Rizzino A
Cytotechnology; 1993; 13(2):69-78. PubMed ID: 7764580
[TBL] [Abstract][Full Text] [Related]
13. Basic fibroblast growth factor in cells derived from Dupuytren's contracture: synthesis, presence, and implications for treatment of the disease.
Lappi DA; Martineau D; Maher PA; Florkiewicz RZ; Buscaglia M; Gonzalez AM; Farris J; Hamer M; Fox R; Baird A
J Hand Surg Am; 1992 Mar; 17(2):324-32. PubMed ID: 1314273
[TBL] [Abstract][Full Text] [Related]
14. A conjugate between human urokinase and saporin, a type-1 ribosome-inactivating protein, is selectively cytotoxic to urokinase receptor-expressing cells.
Cavallaro U; del Vecchio A; Lappi DA; Soria MR
J Biol Chem; 1993 Nov; 268(31):23186-90. PubMed ID: 8226837
[TBL] [Abstract][Full Text] [Related]
15. Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations.
Reiland J; Rapraeger AC
J Cell Sci; 1993 Aug; 105 ( Pt 4)():1085-93. PubMed ID: 8227197
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effects of basic FGF and heparin binding EGF conjugated with cytotoxin saporin on vascular cell cultures.
Chen C; Li J; Micko CJ; Pierce GF; Cunningham MR; Lumsden AB
J Surg Res; 1998 Feb; 75(1):35-41. PubMed ID: 9614854
[TBL] [Abstract][Full Text] [Related]
17. Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors.
Casscells W; Lappi DA; Olwin BB; Wai C; Siegman M; Speir EH; Sasse J; Baird A
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7159-63. PubMed ID: 1323129
[TBL] [Abstract][Full Text] [Related]
18. Large-scale purification and characterization of recombinant fibroblast growth factor-saporin mitotoxin.
McDonald JR; Ong M; Shen C; Parandoosh Z; Sosnowski B; Bussell S; Houston LL
Protein Expr Purif; 1996 Aug; 8(1):97-108. PubMed ID: 8812840
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a saporin mitotoxin specifically cytotoxic to cells bearing the granulocyte-macrophage colony-stimulating factor receptor.
Lappi DA; Martineau D; Sarmientos P; Garofano L; Aranda AP; Miyajima A; Kitamura T; Baird A
Growth Factors; 1993; 9(1):31-9. PubMed ID: 8347350
[TBL] [Abstract][Full Text] [Related]
20. Saporin toxins directed to basic fibroblast growth factor receptors effectively target human ovarian teratocarcinoma in an animal model.
Davol P; Beitz JG; Mohler M; Ying W; Cook J; Lappi DA; Frackelton AR
Cancer; 1995 Jul; 76(1):79-85. PubMed ID: 8630880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
